[Federal Register Volume 80, Number 132 (Friday, July 10, 2015)]
[Notices]
[Pages 39780-39781]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-16893]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-15-0978]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Emerging Infections Program--Revision--(OMB Control No. 0920-0978, 
Expires 8/31/2016), National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Emerging Infections Programs (EIPs) are population-based 
centers of excellence established through a network of state health 
departments collaborating with academic institutions; local health 
departments; public health and clinical laboratories; infection control 
professionals; and healthcare providers. EIPs assist in local, state, 
and national efforts to prevent, control, and monitor the public health 
impact of infectious diseases. Various parts of the EIP have received 
separate Office of Management and Budget (OMB) clearances (Active 
Bacterial Core Surveillance [ABCs]--OMB Control Number 0920-0802 and 
All Age Influenza Hospitalization Surveillance--OMB Control Number 
0920-0852).
    In this revision package we wish to seek OMB clearance to add 
Healthcare Associated Infections--Community Interface (HAIC): active 
population-based surveillance for healthcare associated pathogens and 
infections (including Clostridium difficile infection). There are no 
other changes included in this revision request; therefore, no changes 
are being made to

[[Page 39781]]

the ABC, FoodNet, and Influenza portions of the EIP.
    Activities of the EIPs fall into the following general categories: 
(1) Active surveillance; (2) applied public health epidemiologic and 
laboratory activities; (3) implementation and evaluation of pilot 
prevention/intervention projects; and (4) flexible response to public 
health emergencies.
    Activities of the EIPs are designed to: (1) Address issues that the 
EIP network is particularly suited to investigate; (2) maintain 
sufficient flexibility for emergency response and new problems as they 
arise; (3) develop and evaluate public health interventions to inform 
public health policy and treatment guidelines; (4) incorporate training 
as a key function; and (5) prioritize projects that lead directly to 
the prevention of disease. Proposed respondents will include state 
health departments who may collaborate with one or more of the 
following: academic institutions, local health departments, public 
health and clinical laboratories, infection control professionals, and 
healthcare providers. Frequency of reporting will be determined as 
cases arise.
    The addition of HAIC to the EIP increases the total estimated 
burden by 10,300 hours to 22, 755 hours. There is no cost to 
respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of      Avg. burden
         Type of respondent                   Form name              Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
State Health Department............  ABCs Case Report Form......              10             809           20/60
                                     Invasive Methicillin-                    10             609           20/60
                                      resistant Staphylococcus
                                      aureus ABCs Case Report
                                      Form.
                                     ABCs Invasive Pneumococcal               10              22           10/60
                                      Disease in Children Case
                                      Report Form.
                                     ABCs Non-Bacteremic                      10             100           10/60
                                      Pneumococcal Disease Case
                                      Report Form.
                                     Neonatal Infection Expanded              10              37           20/60
                                      Tracking Form.
                                     ABCs Legionellosis Case                  10             100           20/60
                                      Report Form.
                                     Campylobacter..............              10             637           20/60
                                     Cryptosporidium............              10             130           10/60
                                     Cyclospora.................              10               3           10/60
                                     Listeria monocytogenes.....              10              13           20/60
                                     Salmonella.................              10             827           20/60
                                     Shiga toxin producing E.                 10              90           20/60
                                      coli.
                                     Shigella...................              10             178           10/60
                                     Vibrio.....................              10              20           10/60
                                     Yersinia...................              10              16           10/60
                                     Hemolytic Uremic Syndrome..              10              10               1
                                     Influenza Hospitalization                10             400           15/60
                                      Surveillance Project Case
                                      Report Form.
                                     Influenza Hospitalization                10             100            5/60
                                      Surveillance Project
                                      Vaccination Telephone
                                      Survey.
                                     Influenza Hospitalization                10             100            5/60
                                      Surveillance Project
                                      Vaccination Telephone
                                      Survey Consent Form.
EIP site...........................  CDI Case Report Form.......              10            1650           20/60
                                     CDI Treatment Form.........              10            1650           10/60
                                     Resistant Gram-Negative                  10             500           20/60
                                      Bacilli Case Report Form.
Person in the community infected     Screening Form.............             600               1            5/60
 with C. difficile (CDI Cases).
                                     Telephone interview........             500               1           40/60
    Total
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-16893 Filed 7-9-15; 8:45 am]
BILLING CODE 4163-18-P